Neutralizing Antibody-Resistant Hepatitis C Virus Cell-to-Cell Transmission
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Hepatitis C virus (HCV) can initiate infection by cell-free particle and cell-cell contact-dependent transmission. In this study we use a novel infectious coculture system to examine these alternative modes of infection. Cell-to-cell transmission is relatively resistant to anti-HCV glycoprotein monoclonal antibodies and polyclonal immunoglobulin isolated from infected individuals, providing an effective strategy for escaping host humoral immune responses. Chimeric viruses expressing the structural proteins representing the seven major HCV genotypes demonstrate neutralizing antibody-resistant cell-to-cell transmission. HCV entry is a multistep process involving numerous receptors. In this study we demonstrate that, in contrast to earlier reports, CD81 and the tight-junction components claudin-1 and occludin are all essential for both cell-free and cell-to-cell viral transmission. However, scavenger receptor BI (SR-BI) has a more prominent role in cell-to-cell transmission of the virus, with SR-BI-specific antibodies and small-molecule inhibitors showing preferential inhibition of this infection route. These observations highlight the importance of targeting host cell receptors, in particular SR-BI, to control viral infection and spread in the liver.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K., Habermann, A., Kräusslich, H.-G., Mizokami, M., et al. (2005) · Nature Medicine · doi:10.1038/nm1268 · Cited by 2,754
Complete Replication of Hepatitis C Virus in Cell Culture
Lindenbach, B. D., Evans, M. J., Syder, A. J., Wölk, B., Tellinghuisen, T. L., Liu, C. C., Maruyama, T., Hynes, R. O., Burton, D. R., McKeating, J. A., et al. (2005) · Science · doi:10.1126/science.1114016 · Cited by 2,238
Self-citationRobust hepatitis C virus infection in vitro
Zhong, J., Gastaminza, P., Cheng, G., Kapadia, S., Kato, T., Burton, D. R., Wieland, S. F., Uprichard, S. L., Wakita, T., & Chisari, F. V. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503596102 · Cited by 1,709
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
Evans, M. J., von Hahn, T., Tscherne, D. M., Syder, A. J., Panis, M., Wölk, B., Hatziioannou, T., McKeating, J. A., Bieniasz, P. D., & Rice, C. M. (2007) · Nature · doi:10.1038/nature05654 · Cited by 1,232
Self-citationThe human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus
Scarselli, E., Ansuini, H., Cerino, R., Roccasecca, R. M., Acali, S., Filocamo, G., Traboni, C., Nicosia, A., Cortese, R., & Vitelli, A. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf529 · Cited by 1,177
Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1–E2 Envelope Protein Complexes
Bartosch, B., Dubuisson, J., & Cosset, F.-L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021756 · Cited by 1,111
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
Ploss, A., Evans, M. J., Gaysinskaya, V. A., Panis, M., You, H., de Jong, Y. P., & Rice, C. M. (2009) · Nature · doi:10.1038/nature07684 · Cited by 941
Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles
Hsu, M., Zhang, J., Flint, M., Logvinoff, C., Cheng-Mayer, C., Rice, C. M., & McKeating, J. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0832180100 · Cited by 795
Self-citationExosome Function: From Tumor Immunology to Pathogen Biology
Schorey, J. S., & Bhatnagar, S. (2008) · Traffic · doi:10.1111/j.1600-0854.2008.00734.x · Cited by 758
Cited by
Living in the liver: hepatic infections
Protzer, U., Maini, M. K., & Knolle, P. A. (2012) · Nature Reviews Immunology · doi:10.1038/nri3169 · Cited by 560
The ins and outs of hepatitis C virus entry and assembly
Lindenbach, B. D., & Rice, C. M. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3098 · Cited by 387
Tight junction proteins in gastrointestinal and liver disease
Zeisel, M. B., Dhawan, P., & Baumert, T. F. (2019) · Gut · doi:10.1136/gutjnl-2018-316906 · Cited by 358
Self-citationInnate and adaptive immune responses in HCV infections
Heim, M. H., & Thimme, R. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.06.035 · Cited by 305
(−)-Epigallocatechin- 3 -gallate is a new inhibitor of hepatitis C virus entry
Calland, N., Albecka, A., Belouzard, S., Wychowski, C., Duverlie, G., Descamps, V., Hober, D., Dubuisson, J., Rouillé, Y., & Séron, K. (2012) · Hepatology · doi:10.1002/hep.24803 · Cited by 279
Viral effects on the content and function of extracellular vesicles
Raab-Traub, N., & Dittmer, D. P. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.60 · Cited by 269
SARS-CoV-2 spreads through cell-to-cell transmission
Zeng, C., Evans, J. P., King, T., Zheng, Y.-M., Oltz, E. M., Whelan, S. P. J., Saif, L. J., Peeples, M. E., & Liu, S.-L. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2111400119 · Cited by 246
“Accumulating evidence indicates that viruses, including the highly pathogenic HIV, HCV, and EBOV, etc., can efficiently spread through cell-to-cell transmission (23, 29–31 , 69– 71 ).”
Broadly neutralizing antibodies abrogate established hepatitis C virus infection
de Jong, Y. P., Dorner, M., Mommersteeg, M. C., Xiao, J. W., Balazs, A. B., Robbins, J. B., Winer, B. Y., Gerges, S., Vega, K., Labitt, R. N., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009512 · Cited by 236
Bogdanos, D. P., Gao, B., & Gershwin, M. E. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c120011 · Cited by 185
Zeisel, M. B., Felmlee, D. J., & Baumert, T. F. (2013) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-27340-7_4 · Cited by 179
Self-citationHepatitis C Virus Infection: Host–Virus Interaction and Mechanisms of Viral Persistence
Chigbu, D., Loonawat, R., Sehgal, M., Patel, D., & Jain, P. (2019) · Cells · doi:10.3390/cells8040376 · Cited by 169
“occurring in the hypervariable region 1 of E2 along with the potential of HVR 1 to interfere with the binding of antibodies to E2 [233], (4) the cell to cell transmission of HCV constituting a considerable hindrance to developing B-cell-based HCV vaccines that induce broad cross-neutralizing antibodies since HCV could…”
BackgroundKruglova, N., Siniavin, A., Gushchin, V., & Mazurov, D. (2021) · Viruses · doi:10.3390/v13061133 · Cited by 37
Metadata
- Authors
- Brimacombe, C. L., Grove, J., Meredith, L. W., Hu, K., Syder, A. J., Flores, M. V., Timpe, J. M., Krieger, S. E., Baumert, T. F., Tellinghuisen, T. L., Wong-Staal, F., Balfe, P., & McKeating, J. A.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2011-01
- Volume
- 85
- Issue
- 1
- Pages
- 596-605
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2132046473
- Cited by
- 256
- References
- 39
- FWCI
- 14.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.